AnandRathi

Divi's Laboratories Financial Results

BSE Code: 532488NSE Symbol:DIVISLABISIN: INE361B01024

6747 -40.5(-0.6)

Open (Rs) 6790

Close (Rs) 6787.5

High (Rs) 6887.5

Low (Rs) 6727

Face Value2

Market Capital (Cr.)179111.93

Daily Volume295302

Life Time High7071.5

Life Time Low532.65

52 Week High7071.5

52 Week Low5636.5

Results

Consolidated
IN CRMAR 2026MAR 2025MAR 2024MAR 2023MAR 2022MAR 2021
Net Sales10,560.009,360.007,845.007,767.518,959.836,969.40
Total Expenditure7,119.006,392.005,640.005,399.695,077.894,109.46
PBIDT (Excl OI)3,441.002,968.002,205.002,367.823,881.942,859.94
Other Income507.00352.00339.00344.66113.8762.56
Operating Profit3,948.003,320.002,544.002,712.483,995.812,922.50
Interest23.002.003.000.670.800.87
Exceptional Items-74.000.000.000.000.000.00
PBDT3,851.003,318.002,541.002,711.813,995.012,921.63
Depreciation463.00402.00378.00343.18311.51255.59
Profit Before Tax3,388.002,916.002,163.002,368.633,683.502,666.04
Tax820.00725.00563.00545.25723.05681.75
Provisions and contingencies0.000.000.000.000.000.00
Profit After Tax2,568.002,191.001,600.001,823.382,960.451,984.29
Extraordinary Items0.000.000.000.000.000.00
Prior Period Expenses0.000.000.000.000.000.00
Other Adjustments0.000.000.000.000.000.00
Net Profit2,568.002,191.001,600.001,823.382,960.451,984.29
Equity Capital53.0053.0053.0053.0953.0953.09
Face Value (IN RS)2.002.002.002.002.002.00
Reserves16,708.0014,916.0013,518.0012,714.0011,675.099,241.52
Basic Eps After Extraordinary Items96.9182.6860.3868.69111.5374.75
Basic Eps Before Extraordinary Items96.9182.6860.3868.69111.5374.75
No of Public Share Holdings0.000.000.000.000.000.00
% of Public Share Holdings0.000.000.000.000.000.00
PBIDTM% (Excl OI)32.5931.7128.1130.4843.3341.04
PBIDTM%37.3935.4732.4334.9244.6041.93
PBDTM%36.4735.4532.3934.9144.5941.92
PBTM%32.0831.1527.5730.4941.1138.25
PATM%24.3223.4120.4023.4733.0428.47

FAQs

What are the Net Sales of Divis Laboratories in the financial year 2026?

For FY 2026, Divis Laboratories recorded Net Sales of 10560.00 crores.This figure helps in determining the company’s true revenue after deducting discounts, returns, and allowances from Gross sales.

What is the Operating Profit of Divis Laboratories in 2026?

The Operating Profit of Divis Laboratories for FY 2026 is 3948.00 crores. With this amount, one can assess the profits derived from the company’s core (or primary) operations, excluding interest and taxes.

What is the Profit Before Tax (PBT) of Divis Laboratories in 2026?

In FY 2026, Divis Laboratories posted a Profit Before Tax of 3388.00 croresIt helps to understand whether a company is efficient enough to manage its costs and generate income before eliminating taxes.

What is the Net Profit of Divis Laboratories for 2026?

Divis Laboratories recorded a Net Profit of 2568.00 crores in FY 2026. It is a key indicator of profitability as it gives a more accurate picture of a company’s financial health by considering all costs associated with the business.

What is the Face Value of Divis Laboratories?

The Face Value of Divis Laboratories shares is 2.It indicates the initial capital raised by the company by issuing shares. Face value can determine a stocks current market value at the time of dividends, bonuses, or stock splits.

What is the PAT Margin (PATM%) of Divis Laboratories in 2026?

In FY 2026, the PAT Margin of Divis Laboratories is 24.32 %. This metric provides insights into the company's efficiency in generating profits after paying taxes.

How to open a Demat Account with Anand Rathi to invest in Divis Laboratories?

Open a Demat Account with Anand Rathi using the following steps:

1. Enter your basic details in the form.
2. Upload ID proof, PAN card, and bank details.
3. Complete eKYC online.
4. Start investing in Divis Laboratories using our TradeMobi App or Web Trading Platform.